BR112022016148A2 - Perfil de proteína de célula hospedeira baseado na atividade - Google Patents

Perfil de proteína de célula hospedeira baseado na atividade

Info

Publication number
BR112022016148A2
BR112022016148A2 BR112022016148A BR112022016148A BR112022016148A2 BR 112022016148 A2 BR112022016148 A2 BR 112022016148A2 BR 112022016148 A BR112022016148 A BR 112022016148A BR 112022016148 A BR112022016148 A BR 112022016148A BR 112022016148 A2 BR112022016148 A2 BR 112022016148A2
Authority
BR
Brazil
Prior art keywords
host cell
cell protein
activity
profile based
protein profile
Prior art date
Application number
BR112022016148A
Other languages
English (en)
Inventor
Qiu Haibo
Molden Rosalynn
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of BR112022016148A2 publication Critical patent/BR112022016148A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01001—Carboxylesterase (3.1.1.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
    • G01N30/724—Nebulising, aerosol formation or ionisation
    • G01N30/7266—Nebulising, aerosol formation or ionisation by electric field, e.g. electrospray
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)

Abstract

PERFIL DE PROTEÍNA DE CÉLULA HOSPEDEIRA BASEADO NA ATIVIDADE. A presente invenção refere-se a métodos e sistemas para identificar impurezas de proteína de célula hospedeira que têm atividades enzimáticas em produtos biofarmacêuticos e em amostras durante os processos de fabricação. O presente pedido fornece várias sondas baseadas em atividade para caracterizar diferentes classes de enzimas de impurezas da proteína da célula hospedeira, incluindo sondas contendo moléculas funcionalizadas com marcadores repórter ou baseados em afinidade.
BR112022016148A 2020-02-27 2021-02-27 Perfil de proteína de célula hospedeira baseado na atividade BR112022016148A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202062982346P 2020-02-27 2020-02-27
US202063021181P 2020-05-07 2020-05-07
US202063073125P 2020-09-01 2020-09-01
PCT/US2021/020136 WO2021174153A1 (en) 2020-02-27 2021-02-27 Activity based host cell protein profiling

Publications (1)

Publication Number Publication Date
BR112022016148A2 true BR112022016148A2 (pt) 2022-10-04

Family

ID=75173439

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112022016744A BR112022016744A2 (pt) 2020-02-27 2021-02-27 Métodos para reduzir a degradação de polissorbato em formulações de fármaco
BR112022016148A BR112022016148A2 (pt) 2020-02-27 2021-02-27 Perfil de proteína de célula hospedeira baseado na atividade

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR112022016744A BR112022016744A2 (pt) 2020-02-27 2021-02-27 Métodos para reduzir a degradação de polissorbato em formulações de fármaco

Country Status (11)

Country Link
US (2) US20210268073A1 (pt)
EP (2) EP4111206A1 (pt)
JP (2) JP2023516950A (pt)
KR (2) KR20220147626A (pt)
CN (2) CN115516313A (pt)
AU (2) AU2021228763A1 (pt)
BR (2) BR112022016744A2 (pt)
CA (2) CA3172037A1 (pt)
IL (2) IL295870A (pt)
MX (2) MX2022010601A (pt)
WO (2) WO2021174153A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202045927A (zh) * 2019-02-27 2020-12-16 法商賽諾菲公司 以具內標之lc-ms於樣品中進行聚山梨醇酯定量之方法
WO2022047416A1 (en) * 2020-08-31 2022-03-03 Genentech, Inc. High throughput, fluorescence-based esterase activity assay for assessing polysorbate degradation risk during biopharmaceutical development
US20230408527A1 (en) * 2022-06-17 2023-12-21 Regeneron Pharmaceuticals, Inc. Methods for characterizing host-cell proteins
CN116297915B (zh) * 2023-02-10 2023-12-01 中国食品药品检定研究院 聚山梨酯类辅料的分析鉴定方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1522343A (en) 1923-05-02 1925-01-06 Thom Clarence Magnetic separator
NO155316C (no) 1982-04-23 1987-03-11 Sintef Fremgangsmaate for fremstilling av magnetiske polymerpartikler.
US7087411B2 (en) 1999-06-08 2006-08-08 Regeneron Pharmaceuticals, Inc. Fusion protein capable of binding VEGF
AR102198A1 (es) * 2014-10-09 2017-02-08 Regeneron Pharma Proceso para reducir partículas subvisibles en una formulación farmacéutica
WO2018039499A1 (en) * 2016-08-24 2018-03-01 Regeneron Pharmaceuticals, Inc. Host cell protein modification
CN114206381A (zh) * 2019-07-10 2022-03-18 瑞泽恩制药公司 宿主细胞蛋白水平降低的合成物及其制备方法

Also Published As

Publication number Publication date
EP4111207A1 (en) 2023-01-04
WO2021174151A1 (en) 2021-09-02
BR112022016744A2 (pt) 2022-10-18
KR20220147632A (ko) 2022-11-03
IL295607A (en) 2022-10-01
MX2022010601A (es) 2022-09-09
JP2023516950A (ja) 2023-04-21
CA3172037A1 (en) 2021-09-02
CN115516313A (zh) 2022-12-23
AU2021228763A1 (en) 2022-09-15
AU2021226595A1 (en) 2022-09-22
CN115485562A (zh) 2022-12-16
KR20220147626A (ko) 2022-11-03
JP2023516949A (ja) 2023-04-21
IL295870A (en) 2022-10-01
EP4111206A1 (en) 2023-01-04
US20210270824A1 (en) 2021-09-02
CA3172898A1 (en) 2021-09-02
US20210268073A1 (en) 2021-09-02
MX2022010654A (es) 2022-11-16
WO2021174153A1 (en) 2021-09-02

Similar Documents

Publication Publication Date Title
BR112022016148A2 (pt) Perfil de proteína de célula hospedeira baseado na atividade
Gilany et al. Exploring the human seminal plasma proteome: an unexplored gold mine of biomarker for male infertility and male reproduction disorder
Stonehouse et al. Strategic planning in SMEs–some empirical findings
BRPI0816079B8 (pt) meio de amostra para a análise de um ou mais analitos em uma amostra de teste de fluido e método automatizado para leitura de meio de amostra
GB2568608A (en) Personalized genetic testing
Balachandar et al. Evaluation of the genetic alterations in direct and indirect exposures of hexavalent chromium [Cr (VI)] in leather tanning industry workers North Arcot District, South India
Lorenz Protein tyrosine phosphatase assays
Celardo et al. Caspase-1 is a novel target of p63 in tumor suppression
Verma et al. Inherited metabolic disorders: efficacy of enzyme assays on dried blood spots for the diagnosis of lysosomal storage disorders
de Macedo et al. Strong anion determination in biological fluids by capillary electrophoresis for clinical diagnostics
Zhang et al. Gab2 phosphorylation by RSK inhibits Shp2 recruitment and cell motility
ATE342377T1 (de) Spezifische detektionsmedien für staphylococcus aureus und identifizierungs- und/oder zaehlmethode unter verwendung besagter detektionsmedien
Wilkesman et al. Zymography principles
Schira-Heinen et al. Pitfalls and opportunities in the characterization of unconventionally secreted proteins by secretome analysis
BR112022000322A2 (pt) Um biomarcador para doença de alzheimer com o uso de amostras de sangue de indivíduos clinicamente diagnosticados com doença de alzheimer
Chao et al. Protein tyrosine phosphatase non-receptor type 14 is a novel sperm-motility biomarker
SA522440250B1 (ar) تجارب تسمم عصبي المطثي بأساس خلوي
BR0102781A (pt) Processos para identificação de combinações de entidades como terapêuticos
BR112019025079A2 (pt) Biossensores eletroquímicos
BR112021016967A2 (pt) Composições de anticorpo anti-cd6 e métodos para tratar lúpus
Cieplak et al. Polymer membrane ion-selective electrodes as a convenient tool for lipases and esterases assays
BR112016019104A2 (pt) método para padronizar a sensibilidade de neurônios, método para a geração de neurônios, método para determinar a atividade biológica, uso de gt1b
Gürtler et al. The inter-individual variability outperforms the intra-individual variability of differentially expressed proteins prior and post irradiation in lymphoblastoid cell lines
Schwelberger et al. Characterization of diamine oxidase from human seminal plasma
Woo et al. Efficient identification of phosphorylation by mass spectrometric phosphopeptide fingerprinting